PHARMAZEUTISCHE ZUBEREITUNG FUER DIE INTRAREKTALE VERABREICHUNG VON CALCITONIN UND DARAUS HERGESTELLTE EINZELDOSISFORMEN

New compositions containing a calcitonin as the active ingredient are described which are suitable for the intrarectal administration as soft gelatin capsules or microenemas, wherein the active principle, optionally admixed with a stabilizer, is dissolved in a liquid vehicle consisting of : a) at le...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: LATTANZI, FILIPPO, VANNI, RICCARDO
Format: Patent
Sprache:eng ; ger
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator LATTANZI, FILIPPO
VANNI, RICCARDO
description New compositions containing a calcitonin as the active ingredient are described which are suitable for the intrarectal administration as soft gelatin capsules or microenemas, wherein the active principle, optionally admixed with a stabilizer, is dissolved in a liquid vehicle consisting of : a) at least 70 % by weight of a polyethylene or a polypropylene glycol or a mixture of polyethylene or polypropylene glycols with different molecular weights, having the consistency of a homogeneous fluid at room temperature, and b) less than 15 % by weight of a buffer in a pH range of from 4.5 to 6.5, and optionally c) less than 15 % by weight of an alcohol of 2 to 6 carbon atoms containing two or more hydroxy groups. The new compositions, which do not contain any absorption aid, give calcitonin plasma levels comparable to a conventional intramuscular administration.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_ATE69384TT1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>ATE69384TT1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_ATE69384TT13</originalsourceid><addsrcrecordid>eNqNyrEKwjAQBuAuDqK-w72Agyii4zX9a4IxlculQ5dSJE6igg4-vgo-gNO3fOPidbQsB-6Q1EVjQV0qIXCawo7qBKHKgVxQYcFe2YNaCJefYuz3tE0gw944bYILlEJFFQunSBayQ1R4ryC40MFXTXSxbuSAMC1G5-HyyLOfk4JqqLHzfL_1-XEfTvmanz0r1tvlZqW6WP5R3rp9OyE</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>PHARMAZEUTISCHE ZUBEREITUNG FUER DIE INTRAREKTALE VERABREICHUNG VON CALCITONIN UND DARAUS HERGESTELLTE EINZELDOSISFORMEN</title><source>esp@cenet</source><creator>LATTANZI, FILIPPO ; VANNI, RICCARDO</creator><creatorcontrib>LATTANZI, FILIPPO ; VANNI, RICCARDO</creatorcontrib><description>New compositions containing a calcitonin as the active ingredient are described which are suitable for the intrarectal administration as soft gelatin capsules or microenemas, wherein the active principle, optionally admixed with a stabilizer, is dissolved in a liquid vehicle consisting of : a) at least 70 % by weight of a polyethylene or a polypropylene glycol or a mixture of polyethylene or polypropylene glycols with different molecular weights, having the consistency of a homogeneous fluid at room temperature, and b) less than 15 % by weight of a buffer in a pH range of from 4.5 to 6.5, and optionally c) less than 15 % by weight of an alcohol of 2 to 6 carbon atoms containing two or more hydroxy groups. The new compositions, which do not contain any absorption aid, give calcitonin plasma levels comparable to a conventional intramuscular administration.</description><edition>5</edition><language>eng ; ger</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>1991</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19911115&amp;DB=EPODOC&amp;CC=AT&amp;NR=E69384T1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76516</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19911115&amp;DB=EPODOC&amp;CC=AT&amp;NR=E69384T1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>LATTANZI, FILIPPO</creatorcontrib><creatorcontrib>VANNI, RICCARDO</creatorcontrib><title>PHARMAZEUTISCHE ZUBEREITUNG FUER DIE INTRAREKTALE VERABREICHUNG VON CALCITONIN UND DARAUS HERGESTELLTE EINZELDOSISFORMEN</title><description>New compositions containing a calcitonin as the active ingredient are described which are suitable for the intrarectal administration as soft gelatin capsules or microenemas, wherein the active principle, optionally admixed with a stabilizer, is dissolved in a liquid vehicle consisting of : a) at least 70 % by weight of a polyethylene or a polypropylene glycol or a mixture of polyethylene or polypropylene glycols with different molecular weights, having the consistency of a homogeneous fluid at room temperature, and b) less than 15 % by weight of a buffer in a pH range of from 4.5 to 6.5, and optionally c) less than 15 % by weight of an alcohol of 2 to 6 carbon atoms containing two or more hydroxy groups. The new compositions, which do not contain any absorption aid, give calcitonin plasma levels comparable to a conventional intramuscular administration.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1991</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNyrEKwjAQBuAuDqK-w72Agyii4zX9a4IxlculQ5dSJE6igg4-vgo-gNO3fOPidbQsB-6Q1EVjQV0qIXCawo7qBKHKgVxQYcFe2YNaCJefYuz3tE0gw944bYILlEJFFQunSBayQ1R4ryC40MFXTXSxbuSAMC1G5-HyyLOfk4JqqLHzfL_1-XEfTvmanz0r1tvlZqW6WP5R3rp9OyE</recordid><startdate>19911115</startdate><enddate>19911115</enddate><creator>LATTANZI, FILIPPO</creator><creator>VANNI, RICCARDO</creator><scope>EVB</scope></search><sort><creationdate>19911115</creationdate><title>PHARMAZEUTISCHE ZUBEREITUNG FUER DIE INTRAREKTALE VERABREICHUNG VON CALCITONIN UND DARAUS HERGESTELLTE EINZELDOSISFORMEN</title><author>LATTANZI, FILIPPO ; VANNI, RICCARDO</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_ATE69384TT13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; ger</language><creationdate>1991</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>LATTANZI, FILIPPO</creatorcontrib><creatorcontrib>VANNI, RICCARDO</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>LATTANZI, FILIPPO</au><au>VANNI, RICCARDO</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>PHARMAZEUTISCHE ZUBEREITUNG FUER DIE INTRAREKTALE VERABREICHUNG VON CALCITONIN UND DARAUS HERGESTELLTE EINZELDOSISFORMEN</title><date>1991-11-15</date><risdate>1991</risdate><abstract>New compositions containing a calcitonin as the active ingredient are described which are suitable for the intrarectal administration as soft gelatin capsules or microenemas, wherein the active principle, optionally admixed with a stabilizer, is dissolved in a liquid vehicle consisting of : a) at least 70 % by weight of a polyethylene or a polypropylene glycol or a mixture of polyethylene or polypropylene glycols with different molecular weights, having the consistency of a homogeneous fluid at room temperature, and b) less than 15 % by weight of a buffer in a pH range of from 4.5 to 6.5, and optionally c) less than 15 % by weight of an alcohol of 2 to 6 carbon atoms containing two or more hydroxy groups. The new compositions, which do not contain any absorption aid, give calcitonin plasma levels comparable to a conventional intramuscular administration.</abstract><edition>5</edition><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; ger
recordid cdi_epo_espacenet_ATE69384TT1
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title PHARMAZEUTISCHE ZUBEREITUNG FUER DIE INTRAREKTALE VERABREICHUNG VON CALCITONIN UND DARAUS HERGESTELLTE EINZELDOSISFORMEN
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-14T07%3A40%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=LATTANZI,%20FILIPPO&rft.date=1991-11-15&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EATE69384TT1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true